Cardiff Oncology, Inc. Common Stock (CRDF)
Cardiff Oncology, Inc. (CRDF) is a biopharmaceutical company focused on developing targeted therapies for cancer treatment. It specializes in using precision medicine approaches to identify and develop drugs that can improve outcomes for cancer patients, particularly in areas such as non-small cell lung cancer and other solid tumors.
Company News
The global cancer market is projected to surpass $900 billion by 2034, driven by advancements in cancer treatments from biotech companies like Oncolytics Biotech, Exelixis, Cardiff Oncology, ALX Oncology, and Verastem.
Cardiff Oncology announced positive initial data from a randomized Phase 2 trial evaluating onvansertib in combination with standard-of-care in patients with first-line RAS-mutated metastatic colorectal cancer. The 30mg dose of onvansertib demonstrated a 64% objective response rate, significantly higher than the 33% rate in the control arm.
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Here's 3 top tips for investing in penny stocks in the long term The post Finding Long Term Penny Stocks Investments? 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Costco shares dipped in premarket trading on Wednesday, alongside TrueCar and Morphic Holdings. On the upside, Cardiff Oncology and MillerKnoll shares surged.